Clinical Trial Results:
DABI-ADP-2:
IMPACT OF DABIGATRAN AND PHENPROCOUMON ON CLOPIDOGREL MEDIATED ADP INDUCED PLATELET AGGREGATION IN PATIENTS WITH ATRIAL FIBRILLATION
Summary
|
|
EudraCT number |
2011-000504-18 |
Trial protocol |
DE |
Global completion date |
12 Mar 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Jul 2020
|
First version publication date |
19 Jul 2020
|
Other versions |
|
Summary report(s) |
Dabi-ADP-2 trial: Impact of dabigatran and phenprocoumon on clopidogrel mediated ADP induced platelet aggregation in patients with atrial fibrillation |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.